Tibial Nerve and Sacral Neuromodulation in the Elderly Patient
- 20 Downloads
Purpose of Review
This article aims to review sacral and tibial neuromodulation outcomes in elderly patients. Safety and efficacy of these two neuromodulatory treatments for both urinary and fecal indications are addressed.
Recent data assessing sacral neuromodulation (SNM) for refractory overactive bladder and urge urinary incontinence (UUI) demonstrates that older patients have similar outcomes and complication rates when compared to the general population. For both urinary and fecal indications, SNM has been shown to significantly increase quality of life in older patients. Age has additionally not been a factor affecting tibial nerve stimulation outcomes.
Limited data specifically addresses use of tibial and sacral neuromodulation in elderly patients. Available studies suggest that both treatment options are safe and effective in the older population for urinary and fecal indications, although further study is necessary.
KeywordsPercutaneous tibial nerve stimulation Sacral nerve stimulation Sacral neuromodulation Elderly Overactive bladder Urgency urinary incontinence Fecal incontinence
Compliance with Ethical Standards
Conflict of interest
Ericka Sohlberg, Daniel Greenberg, and Ekene Enemchukwu declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.Gorina Y, Schappert S, Bercovitz A, Elgaddal N, Kramarow E. Prevalence of incontinence among older adults. Vital Health Stat 3. 2014;(36):1–33.Google Scholar
- 4.• Vetrano DL, La Carpia D, Grande G, et al. Anticholinergic medication burden and 5-year risk of hospitalization and death in nursing home elderly residents with coronary artery disease. J Am Med Dir Assoc. 2016. https://doi.org/10.1016/j.jamda.2016.07.012. This study used an objective measurement tool to evaluate anticholinergic burden in a large sample of nursing home residents, showing that anticholinergics increased risk of hospitalization and all—cause mortality.
- 7.Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183:1438–43. https://doi.org/10.1016/j.juro.2009.12.036.CrossRefPubMedGoogle Scholar
- 8.Yoong W, Ridout AE, Damodaram M, Dadswell R. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol. BJU Int. 2010;106:1673–6. https://doi.org/10.1111/j.1464-410X.2010.09461.x.CrossRefPubMedGoogle Scholar
- 10.• Thin NN, Taylor SJC, Bremner SA, Emmanuel AV, Hounsome N, Williams NS, et al. Randomized clinical trial of sacral versus percutaneous tibial nerve stimulation in patients with faecal incontinence. Br J Surg. 2015. https://doi.org/10.1002/bjs.9695 This RCT compared the efficacy of two modalities of neuromodulation for FI.
- 11.• Amundsen CL, Webster GD, Walter A, Amundsen. Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol. 2002. https://doi.org/10.1067/mob.2002.130004 This retrospective case series determined success rates of SNM for refractory urge incontinence in an older population, defined as greater than 55 years of age.
- 12.• White W, Mobley JI, Doggweiler R, Dobmeyer-Dittrich D, FA K. Sacral nerve stimulation for refractory overactive bladder in the elderly population. J Urol. 2009:182(4):1449–52. https://doi.org/10.1016/j.juro.2009.06.049. This prospective longitudinal study determined success and complication rates of SNM for refractory OAB in an elderly population of females greater than 70 years of age.
- 14.• Peters KM, Killinger KA, Gilleran J, Boura JA. Does patient age impact outcomes of neuromodulation? Neurourol Urodyn. 2012. https://doi.org/10.1002/nau. This prospective study of 328 age-stratified OAB patients undergoing staged SNM placement showed no difference in efficacy or complications between age groups.
- 15.• Angioli R, Montera R, Plotti F, Aloisi A, Montone E, Zullo MA. Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up. Int Urogynecol J. 2013. https://doi.org/10.1007/s00192-012-1928-3. This prospective study compared outcomes of SNM for UUI in an elderly population of females greater than 65 years of age.
- 17.Leong RK, SGG DW, Nieman FHM, De Bie RA, Van Kerrebroeck PEV. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn. 2011. https://doi.org/10.1002/nau.20979.
- 25.• George AT, Kalmar K, Goncalves J, Nicholls RJ, Vaizey CJ. Sacral nerve stimulation in the elderly. Colorectal Dis. 2012. https://doi.org/10.1111/j.1463-1318.2011.02568.x. This publication is the only study on SNS treatment for FI exclusively focused on elderly populations, defined as greater than 65 years of age.
- 29.Govaert B, Melenhorst J, Nieman FHM, Bols EMJ, Van Gemert WG, Baeten CG. Factors associated with percutaneous nerve evaluation and permanent sacral nerve modulation outcome in patients with fecal incontinence. Dis Colon Rectum. 2009;52:1688–94. https://doi.org/10.1007/DCR.0b013e3181b55595.CrossRefPubMedGoogle Scholar
- 30.Roy A-L, Gourcerol G, Menard J-F, Michot F, Leroi A-M, Bridoux V. Predictive factors for successful sacral nerve stimulation in the treatment of fecal incontinence: lessons from a comprehensive treatment assessment. Dis Colon Rectum. 2014;57:772–80. https://doi.org/10.1097/DCR.0000000000000115.CrossRefPubMedGoogle Scholar
- 31.• Altomare DF, Giuratrabocchetta S, Knowles CH, Duyos AM, Robert-Yap J, Matzel KE. Long-term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg. 2015. https://doi.org/10.1002/bjs.9740. This study provided long-term outcome results of SNS for FI.
- 33.• Damon H, Barth X, Roman S, Mion F. Sacral nerve stimulation for fecal incontinence improves symptoms, quality of life and patients’ satisfaction: Results of a monocentric series of 119 patients. Int J Colorectal Dis. 2013. https://doi.org/10.1007/s00384-012-1558-8. This retrospective review showed that older patients experienced greater improvement in quality of life with SNS treatment.
- 36.• Schneider MP, Gross T, Bachmann LM, et al. Tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review. Eur Urol. 2015. https://doi.org/10.1016/j.eururo.2015.07.001. This review compared efficacy of acute and chronic TNS for neurogenic LUTS.
- 38.• Edenfield A, Amundsen C, Wu J, Levin P, Siddiqui N. Posterior tibial nerve stimulation for the treatment of fecal incontinence: a systematic evidence review. Obstet Gynecol Surv. 2015;70:329–41. This systematic review studied the efficacy of PTNS for FI. The majority of the studies reviewed reported statistically significant improvement after therapy. CrossRefGoogle Scholar
- 40.• Booth J, Hagen S, McClurg D, Norton C, MacInnes C, Collins B, et al. A feasibility study of transcutaneous posterior tibial nerve stimulation for bladder and bowel dysfunction in elderly adults in residential care. J Am Med Dir Assoc. 2013. https://doi.org/10.1016/j.jamda.2012.10.021. This randomized controlled trial compared outcomes of TTNS compared to placebo in elderly patients treated for both bowel and bladder dysfunction.
- 41.Zinkgraf K, Quinn AO, Ketterhagen D, Kreuziger B, Stevenson K. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population. Urol Nurs. 2009;29(1):30–4.Google Scholar
- 42.• Horrocks E, Chadi S, Stevens N, Wexner S, Knowles C. Factors associated with efficacy of percutaneous tibial nerve stimulation for fecal incontinence, based on post-hoc analysis of data from a randomized trial. Clin Gastroenterol Hepatol. 2017;15:1915–21. Post-hoc analysis of CONFIDeNT Trial showed age was not a predictor of success when using PTNS for FI. CrossRefGoogle Scholar